Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Pulmonology

Building Your Care Team

At a Glance

People with idiopathic chronic eosinophilic pneumonia benefit from coordinated care led by a pulmonologist, with other specialists added when needed. Bring imaging, lab trends, procedure reports, and a medication timeline to support safe treatment and relapse monitoring.

Because Idiopathic Chronic Eosinophilic Pneumonia (ICEP) is so rare, building a care team with specific expertise is important. Managing this condition requires a specialist who not only understands how to treat the initial inflammation but also how to monitor for relapses and safely manage the long-term effects of steroid therapy [1][2].

Your Core Medical Team

Your care is usually led by a pulmonologist (a lung specialist). A pulmonologist experienced with eosinophilic lung diseases can effectively coordinate your care. While access to an academic Interstitial Lung Disease (ILD) center is excellent—especially because they often hold multidisciplinary case reviews with radiologists and pathologists—it is not an absolute requirement if you have a knowledgeable, communicative local specialist [1][3].

Depending on your symptoms, your pulmonologist may collaborate with other specialists when indicated:

  • Primary Care Physician (PCP): Plays a vital role in monitoring for the side effects of long-term steroid use, such as changes in bone density, blood sugar, and blood pressure [4][5].
  • Allergist or Immunologist: Often consulted if you have severe asthma or if your doctor is considering biologic therapies like mepolizumab to lower your steroid dose [6][7].
  • Infectious Disease Specialist: May be involved if your case is complex to help rule out “mimics” like parasites, fungal infections, or tuberculosis that can also cause high eosinophil counts [8][9].
  • Rheumatologist: If you have symptoms outside your lungs—such as joint pain, rashes, or nerve issues—a rheumatologist can help determine if your condition is actually a systemic disease like EGPA [9][10].

Preparing for Your First Specialist Visit

When seeing a specialist for a first visit or a second opinion, having your records organized is critical. The goal is to provide a complete picture of how the disease has behaved over time [11].

Be sure to bring the following items:

  1. Imaging Files: Do not bring just the written reports. Request the actual image files (often called DICOM files, usually on a CD or USB drive) for all chest X-rays and HRCT (High-Resolution CT) scans you have had before, during, and after treatment [11][12].
  2. Dated Laboratory Results: Provide a chronological list of your absolute eosinophil counts from your blood work. It is helpful for the doctor to see these numbers alongside your medication history to understand how you respond to different doses [13][14].
  3. Procedure Reports: If you had a bronchoscopy or a lung biopsy, bring the full report, including the exact percentages of cells found in your lung fluid and any microbiology results [15][16].
  4. Symptom and Medication Log: Create a simple timeline that includes when your symptoms started, any recent travel, new medications or supplements, and a history of your steroid doses (including when you started and stopped them) [17][2].

Evaluating a Specialist

When you meet with a potential specialist, remember that you are evaluating their experience with this specific rare disease. A strong specialist should be able to clearly explain why they believe your condition is “idiopathic” and how they have ruled out other causes [18]. They should also be transparent about the limits of current research, particularly regarding the off-label use of biologics for ICEP [5][19].

If you feel your case is complex, you are relapsing frequently, or you do not live near a major academic center, don’t hesitate to ask your local pulmonologist if they are willing to request a remote second opinion or electronic image transfer for multidisciplinary review [20][1].

Common questions in this guide

Which doctor usually leads treatment for ICEP?
A pulmonologist, or lung specialist, usually coordinates care for idiopathic chronic eosinophilic pneumonia. It is helpful to choose someone familiar with eosinophilic lung diseases who can monitor relapses and long-term steroid effects. An academic interstitial lung disease center can help, but a knowledgeable local specialist may also provide effective care.
What other specialists might I need for ICEP?
A primary care clinician can help monitor bone density, blood sugar, and blood pressure during long-term steroid treatment. An allergy or immune specialist may help with severe asthma or biologic treatment, while an infectious disease specialist can help rule out infections that mimic ICEP. A rheumatologist may be useful when joint pain, rashes, or nerve problems suggest disease beyond the lungs.
What should I bring to an ICEP specialist appointment?
Bring the actual files for prior chest X-rays and high-resolution CT scans, not only the written reports. Also bring dated blood eosinophil results, bronchoscopy or lung biopsy reports with microbiology findings, and a timeline of symptoms, travel, new medicines, supplements, and steroid doses.
How can I tell whether a specialist is experienced with ICEP?
Ask how often they manage eosinophilic lung diseases and how they determine that the pneumonia is idiopathic, meaning no other cause has been found. The specialist should explain how infections, parasites, medicines, and systemic diseases are considered and should be open about the evidence and limits of off-label biologic treatment. You can also ask whether they would arrange a multidisciplinary review or second opinion if your case is complex or relapses.
Can my local doctor get a second opinion for ICEP?
Yes. If the disease is complex, unusual, or keeps returning, your local pulmonologist can ask an academic center for a remote second opinion or multidisciplinary review. Electronic transfer of your imaging and complete records can help the reviewing team assess your case.
How should long-term steroid effects be monitored in ICEP?
Your pulmonologist and primary care clinician can coordinate monitoring while you take steroids. Follow-up may include checking bone health, blood sugar, and blood pressure, along with watching for a return of symptoms. Ask your team what changes should prompt a call between visits.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Do you have experience managing rare eosinophilic lung diseases, or do you have a colleague you consult with for these cases?
  2. 2.Will you coordinate closely with my primary care doctor to manage the side effects of long-term steroids?
  3. 3.Are you comfortable navigating the process for off-label biologic therapies if I relapse or cannot tolerate steroids?
  4. 4.If my case becomes complex or atypical, would you be willing to refer my case for multidisciplinary review or a second opinion?
  5. 5.What is the best way to communicate with your office if I experience a sudden change in symptoms?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (20)
  1. 1

    Survey of physicians' approaches to the clinical evaluation of interstitial lung disease in Singapore (SoPhoCLES).

    Teo FSW, Chai GT, Low SY, et al.

    Journal of thoracic disease 2025; (17(11)):9439-9450 doi:10.21037/jtd-2025-1365.

    PMID: 41377003
  2. 2

    Chronic eosinophilic pneumonia: Adjunctive therapy with inhaled steroids.

    Chan C, DeLapp D, Nystrom P

    Respiratory medicine case reports 2017; (22()):11-14 doi:10.1016/j.rmcr.2017.05.014.

    PMID: 28626631
  3. 3

    Multidisciplinary Evaluation in Patients with Lung Disease Associated with Connective Tissue Disease.

    Wells A, Devaraj A, Renzoni EA, Denton CP

    Seminars in respiratory and critical care medicine 2019; (40(2)):184-193 doi:10.1055/s-0039-1684020.

    PMID: 31137059
  4. 4

    The Long-term Clinical Course of Chronic Eosinophilic Pneumonia.

    Ishiguro T, Takayanagi N, Uozumi R, et al.

    Internal medicine (Tokyo, Japan) 2016; (55(17)):2373-7 doi:10.2169/internalmedicine.55.6765.

    PMID: 27580536
  5. 5

    New perspectives in the treatment of chronic eosinophilic pneumonia in the era of targeted therapies.

    Scelfo C, Simonazzi A, Ruggiero P, et al.

    Frontiers in immunology 2026; (17()):1893402 doi:10.3389/fimmu.2026.1893402.

    PMID: 42666554
  6. 6

    Three-year sustained remission with mepolizumab in a rare eosinophilic disease: idiopathic chronic eosinophilic pneumonia.

    Akten HS, Inan S, Galata Z, et al.

    European clinical respiratory journal 2026; (13(1)):2705048 doi:10.1080/20018525.2026.2705048.

    PMID: 42591896
  7. 7

    Treatments of refractory eosinophilic lung diseases with biologics.

    Asano K, Suzuki Y, Tanaka J, et al.

    Allergology international : official journal of the Japanese Society of Allergology 2023; (72(1)):31-40 doi:10.1016/j.alit.2022.10.004.

    PMID: 36333218
  8. 8

    Chronic Eosinophilic Pneumonia With Overlapping Emphysema and Fibrosis: An Atypical Presentation of Recurrent Pulmonary Tuberculosis.

    Cardona A, Villa-Pérez S, Cohen-Mejía S, et al.

    Cureus 2025; (17(6)):e85228 doi:10.7759/cureus.85228.

    PMID: 40605869
  9. 9

    Eosinophilic Lung Diseases.

    Cottin V

    Immunology and allergy clinics of North America 2023; (43(2)):289-322 doi:10.1016/j.iac.2023.01.002.

    PMID: 37055090
  10. 10

    A Diagnostic Dilemma: Proteinase-3 (PR3)-Positive Anti-neutrophil Cytoplasmic Autoantibodies in Eosinophilic Granulomatosis With Polyangiitis.

    Goldman S, Wilson B, Awan K, et al.

    Cureus 2025; (17(3)):e80365 doi:10.7759/cureus.80365.

    PMID: 40206908
  11. 11

    High-resolution computed tomography findings in chronic eosinophilic vs. cryptogenic organising pneumonia.

    Mehrian P, Doroudinia A, Rashti A, et al.

    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2017; (21(11)):1181-1186 doi:10.5588/ijtld.16.0723.

    PMID: 29037300
  12. 12

    Bronchial involvement in chronic eosinophilic pneumonia: a case report.

    Kim NH, Lee KH, Kim JH, et al.

    Journal of thoracic disease 2015; (7(4)):E97-E101 doi:10.3978/j.issn.2072-1439.2014.12.16.

    PMID: 25973261
  13. 13

    Predictive factors for relapse in corticosteroid-treated patients with chronic eosinophilic pneumonia.

    Takeuchi N, Arai T, Sasaki Y, et al.

    Journal of thoracic disease 2022; (14(11)):4352-4360 doi:10.21037/jtd-22-511.

    PMID: 36524087
  14. 14

    Idiopathic Chronic Eosinophilic Pneumonia.

    Teixeira N, Santos MI, Pedro F, et al.

    Cureus 2021; (13(3)):e14047 doi:10.7759/cureus.14047.

    PMID: 33898133
  15. 15

    Eosinophilic Lung Diseases.

    Cottin V

    Clinics in chest medicine 2016; (37(3)):535-56.

    PMID: 27514599
  16. 16

    Case Report: Chronic eosinophilic pneumonia with acute-like presentation and diagnostic challenges.

    Zamfir AS, Mihailovici AS, Mihai F, et al.

    Frontiers in medicine 2026; (13()):1841565 doi:10.3389/fmed.2026.1841565.

    PMID: 42318416
  17. 17

    Hypersensitivity pneumonitis, allergic bronchopulmonary aspergillosis and other eosinophilic lung diseases.

    Barry J, Gadre A, Akuthota P

    Current opinion in immunology 2020; (66()):129-135 doi:10.1016/j.coi.2020.10.005.

    PMID: 33166785
  18. 18

    Eosinophilic Lung Diseases.

    Cottin V

    Clinics in chest medicine 2025; (46(4)):667-684 doi:10.1016/j.ccm.2025.07.007.

    PMID: 41110928
  19. 19

    Case Report: Mepolizumab in the treatment of idiopathic chronic eosinophilic pneumonia.

    Daboussi S, Essebaa S, Mhamdi S, et al.

    F1000Research 2023; (12()):337 doi:10.12688/f1000research.130939.3.

    PMID: 37691733
  20. 20

    The characterisation of interstitial lung disease multidisciplinary team meetings: a global study.

    Richeldi L, Launders N, Martinez F, et al.

    ERJ open research 2019; (5(2)) doi:10.1183/23120541.00209-2018.

    PMID: 30949489

This page is for informational purposes only and does not constitute medical advice. Your pulmonologist and care team should guide your ICEP treatment, steroid monitoring, and decisions about referrals or biologic therapy.

Get notified when new evidence is published on Idiopathic chronic eosinophilic pneumonia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.